middle.news
AVITA Medical Raises 2026 Revenue Guidance and Targets Q4 Cash Flow Breakeven
8:26am on Friday 7th of August, 2026 AEST
•
Healthcare
Read Story
AVITA Medical Raises 2026 Revenue Guidance and Targets Q4 Cash Flow Breakeven
8:26am on Friday 7th of August, 2026 AEST
Key Points
Q2 revenue up 18% to $21.7 million
Gross margin improves to 81.9%
Operating expenses down 6% year-over-year
Raised 2026 revenue guidance to $86-$89 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Avita Medical (ASX:AVH)
OPEN ARTICLE